NR1H4 and obesity due to melanocortin 4 receptor deficiency: In recent years, studies have found that FXR plays an important role in human glucose and lipid metabolism, and its abnormal activation can promote fatty liver, T2DM, dyslipidemia, obesity, and other diseases [23–25].